Abstract: This medicament characterized by containing, together or separately in combination with a HDAC inhibitor, an antibody or a fragment thereof having an immunological reactivity with a CAPRIN-1 protein is useful as a medicament for treatment and/or prevention of cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202417009282-STATEMENT OF UNDERTAKING (FORM 3) [12-02-2024(online)].pdf | 2024-02-12 |
| 4 | 202417009282-Sequence Listing in PDF [12-02-2024(online)].pdf | 2024-02-12 |
| 5 | 202417009282-PROOF OF RIGHT [12-02-2024(online)].pdf | 2024-02-12 |
| 6 | 202417009282-POWER OF AUTHORITY [12-02-2024(online)].pdf | 2024-02-12 |
| 7 | 202417009282-FORM 1 [12-02-2024(online)].pdf | 2024-02-12 |
| 8 | 202417009282-FIGURE OF ABSTRACT [12-02-2024(online)].pdf | 2024-02-12 |
| 9 | 202417009282-DRAWINGS [12-02-2024(online)].pdf | 2024-02-12 |
| 10 | 202417009282-DECLARATION OF INVENTORSHIP (FORM 5) [12-02-2024(online)].pdf | 2024-02-12 |
| 11 | 202417009282-COMPLETE SPECIFICATION [12-02-2024(online)].pdf | 2024-02-12 |
| 12 | 202417009282-certified copy of translation [24-02-2024(online)].pdf | 2024-02-24 |
| 13 | 202417009282-FORM 3 [09-08-2024(online)].pdf | 2024-08-09 |
| 14 | 202417009282-MARKED COPIES OF AMENDEMENTS [07-07-2025(online)].pdf | 2025-07-07 |
| 15 | 202417009282-FORM 13 [07-07-2025(online)].pdf | 2025-07-07 |
| 16 | 202417009282-AMMENDED DOCUMENTS [07-07-2025(online)].pdf | 2025-07-07 |
| 17 | 202417009282-FORM 18 [08-07-2025(online)].pdf | 2025-07-08 |